{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:pad:pad-025-drug-eluting-stent",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-06T06:00:00.000Z",
    "last_updated": "2026-01-06T06:00:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "copyright_compliance": "Original content based on general medical knowledge",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/pad",
    "type": "endovascular-technique",
    "difficulty": "advanced",
    "importance": "critical",
    "aku_id": "PAD-025",
    "keywords": [
      "drug-eluting stent",
      "DES",
      "paclitaxel",
      "femoropopliteal",
      "Zilver PTX"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "lower_extremity_arterial_disease",
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Drug-Eluting Stents in Peripheral Arterial Disease",
    "statement": "Drug-Eluting Stents in Peripheral Arterial Disease is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Pad that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Drug-Eluting Stents in Peripheral Arterial Disease helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Drug-Eluting Stents in Peripheral Arterial Disease include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Drug-Eluting Stents in Peripheral Arterial Disease."
    },
    "stent_technology": {
      "platform": {
        "material": "Nitinol (nickel-titanium alloy)",
        "design": "Self-expanding, laser-cut",
        "sizing": "Oversized 1-2 mm to reference vessel"
      },
      "drug_component": {
        "agent": "Paclitaxel",
        "delivery": "Polymer-based sustained release",
        "duration": "Drug release over weeks to months"
      },
      "deployment": {
        "technique": "Unsheathing, no balloon inflation required",
        "post_dilation": "Balloon to ensure full apposition"
      }
    },
    "clinical_indications": {
      "primary_indications": [
        "Bailout for flow-limiting dissection",
        "Significant elastic recoil (>30% residual stenosis)",
        "Suboptimal result after DCB/POBA"
      ],
      "lesion_characteristics": [
        "Femoropopliteal lesions up to 14-15 cm",
        "TASC C/D lesions when endovascular chosen",
        "Moderate to heavy calcification"
      ],
      "relative_contraindications": [
        "Across-knee deployment (high fracture risk)",
        "Severe calcification without preparation",
        "In-stent restenosis (consider DCB instead)"
      ]
    },
    "clinical_evidence": {
      "zilver_ptx": {
        "design": "RCT of DES vs PTA with provisional BMS",
        "primary_patency_1yr": "83.1% vs 32.8% for BMS",
        "primary_patency_5yr": "66.4%",
        "significance": "First FDA-approved peripheral DES"
      },
      "comparison_dcb": {
        "general_approach": "DCB-first strategy, DES for bailout",
        "evidence": "Non-inferior outcomes with less permanent implant"
      }
    },
    "outcomes": {
      "primary_patency": {
        "one_year": "80-85%",
        "two_year": "70-75%",
        "five_year": "65-70%"
      },
      "complications": {
        "stent_fracture": "2-5% depending on location",
        "in_stent_restenosis": "15-25% at 2 years",
        "thrombosis": "Rare with appropriate antiplatelet therapy"
      }
    },
    "antiplatelet_therapy": {
      "dapt_duration": "At least 3-6 months",
      "regimen": "Aspirin + clopidogrel",
      "long_term": "Single antiplatelet indefinitely"
    },
    "terminology": {
      "snomed_ct": "360046005",
      "icd_10": "Z95.828"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Drug-Eluting Stent in PAD"
    },
    "altLabel": [
      "Peripheral DES",
      "Paclitaxel-Eluting Stent",
      "Zilver PTX"
    ],
    "definition": {
      "@language": "en",
      "@value": "Self-expanding nitinol stent with polymer-based drug coating for sustained antiproliferative drug release in peripheral arterial disease."
    },
    "notation": "PAD-025"
  },
  "clinical_features": {
    "presentation": [
      "Failed primary angioplasty (dissection, recoil)",
      "Long femoropopliteal lesions",
      "TASC C/D lesions selected for endovascular"
    ],
    "diagnosis": [
      "Completion angiography showing suboptimal result",
      "Flow-limiting dissection",
      ">30% residual stenosis"
    ],
    "treatment": [
      "Appropriate vessel sizing",
      "DES deployment with post-dilation",
      "Dual antiplatelet therapy",
      "Duplex surveillance"
    ]
  },
  "relationships": {
    "prerequisites": [
      "vascular:pad:pad-024-dcb",
      "vascular:endovascular:stent-basics"
    ],
    "enables": [
      "vascular:pad:patency-restoration",
      "vascular:pad:limb-salvage"
    ],
    "skos:broader": [
      "vascular:pad:endovascular-techniques"
    ],
    "skos:related": [
      "vascular:pad:pad-024-dcb",
      "vascular:pad:in-stent-restenosis"
    ],
    "skos:narrower": []
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Drug-Eluting Stents in Peripheral Arterial Disease. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "interventional radiology fellows"
    ],
    "estimated_time": "15min",
    "learning_objectives": [
      "Identify appropriate indications for peripheral drug-eluting stents",
      "Compare DES vs DCB strategies in femoropopliteal disease",
      "Describe optimal deployment technique for self-expanding DES",
      "Prescribe appropriate antiplatelet therapy after DES"
    ],
    "clinical_pearls": [
      "DCB-first, DES for bailout is the modern strategy",
      "Avoid stenting across the knee - high fracture rates",
      "Size 1-2 mm larger than reference vessel for self-expanding stents",
      "Post-dilate to ensure full stent apposition",
      "DAPT for at least 3-6 months after DES"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codeValue": "360046005",
      "codingSystem": "SNOMED-CT",
      "name": "Drug-eluting stent insertion"
    },
    {
      "@type": "MedicalCode",
      "codeValue": "37226",
      "codingSystem": "CPT",
      "name": "Transluminal peripheral stent placement, femoral/popliteal"
    },
    {
      "@type": "MedicalCode",
      "codeValue": "C1874",
      "codingSystem": "HCPCS",
      "name": "Drug-eluting stent, peripheral"
    }
  ]
}